{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:43:43Z","timestamp":1793277823191,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CAP 48"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Serum protein glycosylation is an area of investigation in inflammatory arthritic disorders such as rheumatoid arthritis (RA). Indeed, some studies highlighted abnormalities of protein glycosylation in RA. Considering the numerous types of enzymes, monosaccharides and glycosidic linkages, glycosylation is one of the most complex post translational modifications. By this work, we started with a preliminary screening of glycoproteins in serum from RA patients and controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In order to isolate glycoproteins from serum, lectin wheat germ agglutinin was used and quantitative differences between patients and controls were investigated by LC\u2013MS\/MS. Consequently, we focused our attention on two glycoproteins found in this explorative phase: corticosteroid-binding globulin (CBG) and lipopolysaccharide-binding protein (LBP). The subsequent validation with immunoassays was widened to a larger number of early RA (ERA) patients (n\u2009=\u200990) and well-matched healthy controls (n\u2009=\u200990).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We observed a significant reduction of CBG and LBP glycosylation in ERA patients compared with healthy controls. Further, after 12\u00a0months of treatment, glycosylated CBG and LBP levels increased both to values comparable to those of controls. In addition, these changes were correlated with clinical parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study enables to observe that glycosylation changes of CBG and LBP are related to RA disease activity and its response to treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12967-019-02188-9","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T18:04:00Z","timestamp":1578333840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Glycosylation deficiency of lipopolysaccharide-binding protein and corticosteroid-binding globulin associated with activity and response to treatment for rheumatoid arthritis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-9249","authenticated-orcid":false,"given":"Federica","family":"Ciregia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Baiwir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Cobraiville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Dewael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Mazzucchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Badot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Di Romana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Sidiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel G.","family":"Malaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"de Seny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"2188_CR1","doi-asserted-by":"publisher","first-page":"010409","DOI":"10.7189\/jogh.05.010101","volume":"5","author":"I Rudan","year":"2015","unstructured":"Rudan I, Sidhu S, Papana A, Meng SJ, Xin-Wei Y, Wang W, Global Health Epidemiology Reference Group (GHERG), et al. Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis. J Glob Health. 2015;5:010409.","journal-title":"J Glob Health."},{"key":"2188_CR2","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"2188_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/316452a0","volume":"316","author":"RB Parekh","year":"1985","unstructured":"Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985;316:452\u20137.","journal-title":"Nature"},{"key":"2188_CR4","first-page":"543","volume":"68","author":"MG Malaise","year":"1987","unstructured":"Malaise MG, Franchimont P, Bouillene C, Houssier C, Mahieu PR. Increased concanavalin A-binding capacity of immunoglobulin G purified from sera of patients with rheumatoid arthritis. Clin Exp Immunol. 1987;68:543\u201351.","journal-title":"Clin Exp Immunol"},{"key":"2188_CR5","first-page":"1379","volume":"27","author":"A Alavi","year":"2000","unstructured":"Alavi A, Arden N, Spector TD, Axford JS. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol. 2000;27:1379\u201385.","journal-title":"J Rheumatol"},{"key":"2188_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/ard.2008.089292","volume":"68","author":"K Van Beneden","year":"2009","unstructured":"Van Beneden K, Coppieters K, Laroy W, De Keyser F, Hoffman IE, Van den Bosch F, et al. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann Rheum Dis. 2009;68:1360\u20135.","journal-title":"Ann Rheum Dis"},{"key":"2188_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2478\/s11658-014-0205-5","volume":"19","author":"P Salahuddin","year":"2014","unstructured":"Salahuddin P, Rabbani G, Khan RH. The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach. Cell Mol Biol Lett. 2014;19:407\u201337.","journal-title":"Cell Mol Biol Lett"},{"key":"2188_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1474-9726.2011.00752.x","volume":"11","author":"T Uchiki","year":"2012","unstructured":"Uchiki T, Weikel KA, Jiao W, Shang F, Caceres A, Pawlak D, et al. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell. 2012;11:1\u201313.","journal-title":"Aging Cell"},{"key":"2188_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/rp.56.1.1","volume":"56","author":"P Ulrich","year":"2001","unstructured":"Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001;56:1\u201321.","journal-title":"Recent Prog Horm Res"},{"key":"2188_CR10","doi-asserted-by":"publisher","first-page":"43R","DOI":"10.1093\/glycob\/12.4.43R","volume":"12","author":"RG Spiro","year":"2002","unstructured":"Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology. 2002;12:43R\u201356R.","journal-title":"Glycobiology"},{"key":"2188_CR11","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1021\/pr500146y","volume":"13","author":"C McCarthy","year":"2014","unstructured":"McCarthy C, Saldova R, Wormald MR, Rudd PM, McElvaney NG, Reeves EP. The role and importance of glycosylation of acute phase proteins with focus on alpha-1 antitrypsin in acute and chronic inflammatory conditions. J Proteome Res. 2014;13:3131\u201343.","journal-title":"J Proteome Res"},{"key":"2188_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1023\/A:1011010206774","volume":"17","author":"H Schachter","year":"2000","unstructured":"Schachter H. The joys of HexNAc. The synthesis and function of N- and O-glycan branches. Glycoconj J. 2000;17:465\u201383.","journal-title":"Glycoconj J"},{"key":"2188_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pharmthera.2018.06.003","volume":"191","author":"S Bousseau","year":"2018","unstructured":"Bousseau S, Vergori L, Soleti R, Lenaers G, Martinez MC, Andriantsitohaina R. Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis. Pharmacol Ther. 2018;191:92\u2013122.","journal-title":"Pharmacol Ther"},{"key":"2188_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tibs.2016.11.003","volume":"42","author":"JP Cerliani","year":"2017","unstructured":"Cerliani JP, Blidner AG, Toscano MA, Croci DO, Rabinovich GA. Translating the \u2018Sugar Code\u2019 into immune and vascular signaling programs. Trends Biochem Sci. 2017;42:255\u201373.","journal-title":"Trends Biochem Sci"},{"key":"2188_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540\u201355.","journal-title":"Nat Rev Cancer"},{"key":"2188_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","volume":"10","author":"SR Stowell","year":"2015","unstructured":"Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol. 2015;10:473\u2013510.","journal-title":"Annu Rev Pathol"},{"key":"2188_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/CBM-130373","volume":"14","author":"S Albrecht","year":"2014","unstructured":"Albrecht S, Unwin L, Muniyappa M, Rudd PM. Glycosylation as a marker for inflammatory arthritis. Cancer Biomark. 2014;14:17\u201328.","journal-title":"Cancer Biomark"},{"key":"2188_CR18","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1038\/srep04347","volume":"4","author":"M Novokmet","year":"2014","unstructured":"Novokmet M, Luki\u0107 E, Vu\u010dkovi\u0107 F, \u00d0uri\u0107 \u017d, Keser T, Raj\u0161l K, et al. Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci Rep. 2014;4:4347.","journal-title":"Sci Rep"},{"key":"2188_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1155\/2008\/493289","volume":"25","author":"O Gornik","year":"2008","unstructured":"Gornik O, Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers. 2008;25:267\u201378.","journal-title":"Dis Markers"},{"key":"2188_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10719-006-7922-6","volume":"23","author":"SK Raghav","year":"2006","unstructured":"Raghav SK, Gupta B, Agrawal C, Saroha A, Das RH, Chaturvedi VP, et al. Altered expression and glycosylation of plasma proteins in rheumatoid arthritis. Glycoconj J. 2006;23:167\u201373.","journal-title":"Glycoconj J"},{"key":"2188_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00296-013-2921-y","volume":"34","author":"L Chrostek","year":"2014","unstructured":"Chrostek L, Cylwik B, Gindzienska-Sieskiewicz E, Gruszewska E, Szmitkowski M, Sierakowski S. Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases. Rheumatol Int. 2014;34:393\u20139.","journal-title":"Rheumatol Int"},{"key":"2188_CR22","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1007\/s00216-017-0302-1","volume":"409","author":"C Huang","year":"2017","unstructured":"Huang C, Liu Y, Wu H, Sun D, Li Y. Characterization of IgG glycosylation in rheumatoid arthritis patients by MALDI-TOF-MSn and capillary electrophoresis. Anal Bioanal Chem. 2017;409:3731\u20139.","journal-title":"Anal Bioanal Chem"},{"key":"2188_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/RHU.0000000000000808","volume":"25","author":"M Gudowska","year":"2019","unstructured":"Gudowska M, Gruszewska E, Wrona A, Gindzienska-Sieskiewicz E, Domyslawska I, Lipartowska-Klimuk K, et al. The profile of serum transferrin isoforms in rheumatoid arthritis. J Clin Rheumatol. 2019;25:159\u201362.","journal-title":"J Clin Rheumatol"},{"key":"2188_CR24","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360\u201372.","journal-title":"JAMA"},{"key":"2188_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/cen.13081","volume":"85","author":"MA Nenke","year":"2016","unstructured":"Nenke MA, Lewis JG, Rankin W, McWilliams L, Metcalf RG, Proudman SM, et al. Reduced corticosteroid-binding globulin cleavage in active rheumatoid arthritis. Clin Endocrinol. 2016;85:369\u201377.","journal-title":"Clin Endocrinol"},{"key":"2188_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1530\/JME-17-0234","volume":"60","author":"M Simard","year":"2018","unstructured":"Simard M, Underhill C, Hammond GL. Functional implications of corticosteroid-binding globulin N-glycosylation. J Mol Endocrinol. 2018;60:71\u201384.","journal-title":"J Mol Endocrinol"},{"key":"2188_CR27","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1021\/bi00185a012","volume":"33","author":"GV Avvakumov","year":"1994","unstructured":"Avvakumov GV, Hammond GL. Glycosylation of human corticosteroid-binding globulin. Differential processing and significance of carbohydrate chains at individual sites. Biochemistry. 1994;33:5759\u201365.","journal-title":"Biochemistry"},{"key":"2188_CR28","first-page":"1224","volume":"22","author":"D Heumann","year":"1995","unstructured":"Heumann D, Bas S, Gallay P, Le Roy D, Barras C, Mensi N, et al. Lipopolysaccharide binding protein as a marker of inflammation in synovial fluid of patients with arthritis: correlation with interleukin 6 and C-reactive protein. J Rheumatol. 1995;22:1224\u20139.","journal-title":"J Rheumatol"},{"key":"2188_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ijbiomac.2017.12.075","volume":"109","author":"D Kim","year":"2018","unstructured":"Kim D, Mun S, Lee J, Park A, Seok A, Chun YT, et al. Proteomics analysis reveals differential pattern of widespread protein expression and novel role of histidine-rich glycoprotein and lipopolysaccharide-binding protein in rheumatoid arthritis. Int J Biol Macromol. 2018;109:704\u201310.","journal-title":"Int J Biol Macromol"},{"key":"2188_CR30","first-page":"233","volume":"36","author":"W Wen","year":"2018","unstructured":"Wen W, Li Y, Cheng Y, He J, Jia R, Li C, et al. Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis. Clin Exp Rheumatol. 2018;36:233\u201340.","journal-title":"Clin Exp Rheumatol"},{"key":"2188_CR31","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteom. 2014;13:2513\u201326.","journal-title":"Mol Cell Proteom"},{"key":"2188_CR32","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1016\/S0021-9258(18)50686-4","volume":"254","author":"VP Bhavanandan","year":"1979","unstructured":"Bhavanandan VP, Katlic AW. The interaction of wheat germ agglutinin with sialoglycoproteins. The role of sialic acid. J Biol Chem. 1979;254:4000\u20138.","journal-title":"J Biol Chem"},{"key":"2188_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0304-4165(65)90270-9","volume":"97","author":"IJ Goldstein","year":"1965","unstructured":"Goldstein IJ, Hollerman CE, Merrick JM. Protein-carbohydrate interaction. I. The interaction of polysaccharides with concanavalin A. Biochim Biophys Acta. 1965;97:68\u201376.","journal-title":"Biochim Biophys Acta"},{"key":"2188_CR34","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1021\/bi00881a013","volume":"4","author":"IJ Goldstein","year":"1965","unstructured":"Goldstein IJ, Hollerman CE, Smith EE. Protein-carbohydrate interaction. II. Inhibition studies on the interaction of concanavalin A with polysaccharides. Biochemistry. 1965;4:876\u201383.","journal-title":"Biochemistry"},{"key":"2188_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u20138.","journal-title":"Arthritis Rheum"},{"key":"2188_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van \u2018t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39:34\u201340.","journal-title":"Arthritis Rheum"},{"key":"2188_CR37","first-page":"S40","volume":"34","author":"PL van Riel","year":"2016","unstructured":"van Riel PL, Renskers L. The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34:S40\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"2188_CR38","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/art.1780341113","volume":"34","author":"A Young","year":"1991","unstructured":"Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, et al. Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum. 1991;34:1425\u20139.","journal-title":"Arthritis Rheum"},{"key":"2188_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/glycob\/cwq051","volume":"20","author":"A Knezevic","year":"2010","unstructured":"Knezevic A, Gornik O, Polasek O, Pucic M, Redzic I, Novokmet M, et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology. 2010;20:959\u201369.","journal-title":"Glycobiology"},{"key":"2188_CR40","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1084\/jem.167.5.1731","volume":"167","author":"R Parekh","year":"1988","unstructured":"Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med. 1988;167:1731\u20136.","journal-title":"J Exp Med"},{"key":"2188_CR41","doi-asserted-by":"publisher","first-page":"e89703","DOI":"10.1172\/jci.insight.89703","volume":"2","author":"A Ercan","year":"2017","unstructured":"Ercan A, Kohrt WM, Cui J, Deane KD, Pezer M, Yu EW, et al. Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2017;2:e89703.","journal-title":"JCI Insight"},{"key":"2188_CR42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.immuni.2013.09.005","volume":"39","author":"JK Eckert","year":"2013","unstructured":"Eckert JK, Kim YJ, Kim JI, G\u00fcrtler K, Oh DY, Sur S, et al. The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity. Immunity. 2013;39:647\u201360.","journal-title":"Immunity"},{"key":"2188_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.tice.2016.03.010","volume":"48","author":"E Balcan","year":"2016","unstructured":"Balcan E. Quantitative approach to lectin-based glycoprofiling of the thymic tissues in the control- and the dexamethasone-treated mice. Tissue Cell. 2016;48:168\u201382.","journal-title":"Tissue Cell"},{"key":"2188_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0300-9084(03)00060-9","volume":"85","author":"E Duverger","year":"2003","unstructured":"Duverger E, Frison N, Roche AC, Monsigny M. Carbohydrate-lectin interactions assessed by surface plasmon resonance. Biochimie. 2003;85:167\u201379.","journal-title":"Biochimie"},{"key":"2188_CR45","doi-asserted-by":"publisher","first-page":"14223","DOI":"10.1074\/jbc.275.19.14223","volume":"275","author":"TK Dam","year":"2000","unstructured":"Dam TK, Roy R, Das SK, Oscarson S, Brewer CF. Binding of multivalent carbohydrates to concanavalin A and Dioclea grandiflora lectin. Thermodynamic analysis of the \u201cmultivalency effect\u201d. J Biol Chem. 2000;275:14223\u201330.","journal-title":"J Biol Chem"},{"key":"2188_CR46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.bios.2014.03.040","volume":"59","author":"FS Coulibaly","year":"2014","unstructured":"Coulibaly FS, Youan BB. Concanavalin A-polysaccharides binding affinity analysis using a quartz crystal microbalance. Biosens Bioelectron. 2014;59:404\u201311.","journal-title":"Biosens Bioelectron"},{"key":"2188_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","volume":"33","author":"F Clerc","year":"2016","unstructured":"Clerc F, Reiding KR, Jansen BC, Kammeijer GS, Bondt A, Wuhrer M. Human plasma protein N-glycosylation. Glycoconj J. 2016;33:309\u201343.","journal-title":"Glycoconj J"},{"key":"2188_CR48","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1210\/endo-125-3-1424","volume":"125","author":"Y Murata","year":"1989","unstructured":"Murata Y, Sueda K, Seo H, Matsui N. Studies on the role of glycosylation for human corticosteroid-binding globulin: comparison with that for thyroxine-binding globulin. Endocrinology. 1989;125:1424\u20139.","journal-title":"Endocrinology"},{"key":"2188_CR49","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","volume":"9","author":"PG de Groot","year":"2011","unstructured":"de Groot PG, Meijers JC. \u03b2(2)-Glycoprotein I: evolution, structure and function. J Thromb Haemost. 2011;9:1275\u201384.","journal-title":"J Thromb Haemost"},{"key":"2188_CR50","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1096\/fj.201700018R","volume":"31","author":"A Yang","year":"2017","unstructured":"Yang A, Zhou J, Wang B, Dai J, Colman RW, Song W, et al. A critical role for plasma kallikrein in the pathogenesis of autoantibody-induced arthritis. FASEB J. 2017;31:5419\u201331.","journal-title":"FASEB J"},{"key":"2188_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0009-8981(01)00803-8","volume":"317","author":"I Ryd\u00e9n","year":"2002","unstructured":"Ryd\u00e9n I, P\u00e5hlsson P, Lundblad A, Skogh T. Fucosylation of alpha1-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis. Clin Chim Acta. 2002;317:221\u20139.","journal-title":"Clin Chim Acta"},{"key":"2188_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jprot.2009.08.007","volume":"73","author":"A Kondo","year":"2009","unstructured":"Kondo A, Miyamoto T, Yonekawa O, Giessing AM, \u00d8sterlund EC, Jensen ON. Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome. J Proteom. 2009;73:123\u201333.","journal-title":"J Proteom"},{"key":"2188_CR53","doi-asserted-by":"publisher","first-page":"638129","DOI":"10.1155\/2015\/638129","volume":"2015","author":"C Fickentscher","year":"2015","unstructured":"Fickentscher C, Magorivska I, Janko C, Biermann M, Bilyy R, Nalli C, et al. The pathogenicity of Anti-\u03b22GP1-IgG autoantibodies depends on Fc glycosylation. J Immunol Res. 2015;2015:638129.","journal-title":"J Immunol Res"},{"key":"2188_CR54","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/acr.23449","volume":"70","author":"S Colliard","year":"2018","unstructured":"Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, et al. Autoantibodies targeting ficolin-2 in systemic lupus erythematosus patients with active nephritis. Arthritis Care Res. 2018;70:1263\u20138.","journal-title":"Arthritis Care Res"},{"key":"2188_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","volume":"43","author":"JJ Anderson","year":"2000","unstructured":"Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 2000;43:22\u20139.","journal-title":"Arthritis Rheum"},{"key":"2188_CR56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.rdc.2017.04.008","volume":"43","author":"J Bluett","year":"2017","unstructured":"Bluett J, Barton A. Precision medicine in rheumatoid arthritis. Rheum Dis Clin North Am. 2017;43:377\u201387.","journal-title":"Rheum Dis Clin North Am"},{"key":"2188_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1272\/jnms.JNMS.2019_86-303","volume":"86","author":"K Takahashi","year":"2019","unstructured":"Takahashi K, Nakamura H, Watanabe A, Majima T, Koiwa M, Kamada T, et al. Polymorphism in organic anion-transporting polypeptide gene related to methotrexate response in rheumatoid arthritis treatment. J Nippon Med Sch. 2019;86:149\u201358.","journal-title":"J Nippon Med Sch"},{"key":"2188_CR58","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar4555","volume":"16","author":"G Dennis Jr","year":"2014","unstructured":"Dennis G Jr, Holweg CT, Kummerfeld SK, Choy DF, Setiadi AF, Hackney JA, et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther. 2014;16:R90.","journal-title":"Arthritis Res Ther"},{"key":"2188_CR59","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3389\/fimmu.2018.01302","volume":"9","author":"YY Luan","year":"2018","unstructured":"Luan YY, Yao YM. The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front Immunol. 2018;9:1302.","journal-title":"Front Immunol"},{"key":"2188_CR60","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol"},{"key":"2188_CR61","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1189\/jlb.3VMR0315-080R","volume":"98","author":"RD Ye","year":"2015","unstructured":"Ye RD, Sun L. Emerging functions of serum amyloid A in inflammation. J Leukoc Biol. 2015;98:923\u20139.","journal-title":"J Leukoc Biol"},{"key":"2188_CR62","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448\u201354.","journal-title":"N Engl J Med"},{"key":"2188_CR63","doi-asserted-by":"publisher","first-page":"M111-009100","DOI":"10.1074\/mcp.M111.009100","volume":"10","author":"Z Sumer-Bayraktar","year":"2011","unstructured":"Sumer-Bayraktar Z, Kolarich D, Campbell MP, Ali S, Packer NH, Thaysen-Andersen M. N-Glycans modulate the function of human corticosteroid-binding globulin. Mol Cell Proteom. 2011;10:M111-009100.","journal-title":"Mol Cell Proteom"},{"key":"2188_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/17446651.2017.1332991","volume":"12","author":"EJ Meyer","year":"2017","unstructured":"Meyer EJ, Nenke MA, Lewis JG, Torpy DJ. Corticosteroid-binding globulin: acute and chronic inflammation. Expert Rev Endocrinol Metab. 2017;12:241\u201351.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2188_CR65","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1210\/jc.2012-4280","volume":"98","author":"WL Chan","year":"2013","unstructured":"Chan WL, Carrell RW, Zhou A, Read RJ. How changes in affinity of corticosteroid-binding globulin modulate free cortisol concentration. J Clin Endocrinol Metab. 2013;98:3315\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"2188_CR66","first-page":"1","volume":"14","author":"PS Lim","year":"2018","unstructured":"Lim PS, Chang YK, Wu TK. Serum lipopolysaccharide-binding protein is associated with chronic inflammation and metabolic syndrome in hemodialysis patients. Blood Purif. 2018;14:1\u20139.","journal-title":"Blood Purif"},{"key":"2188_CR67","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1128\/MCB.16.7.3490","volume":"16","author":"RR Schumann","year":"1996","unstructured":"Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, et al. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF\/STAT\/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol. 1996;16:3490\u2013503.","journal-title":"Mol Cell Biol"},{"key":"2188_CR68","first-page":"24","volume":"32","author":"A Stasi","year":"2017","unstructured":"Stasi A, Intini A, Divella C, Franzin R, Montemurno E, Grandaliano G, et al. Emerging role of lipopolysaccharide binding protein in sepsis-induced acute kidney injury. Nephrol Dial Transplant. 2017;32:24\u201331.","journal-title":"Nephrol Dial Transplant"},{"key":"2188_CR69","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1086\/346046","volume":"187","author":"L Blairon","year":"2003","unstructured":"Blairon L, Wittebole X, Laterre PF. Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J Infect Dis. 2003;187:287\u201391.","journal-title":"J Infect Dis"},{"key":"2188_CR70","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1086\/315093","volume":"180","author":"SM Opal","year":"1999","unstructured":"Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis. 1999;180:1584\u20139.","journal-title":"J Infect Dis"},{"key":"2188_CR71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.jp.7211422","volume":"26","author":"T Orlikowsky","year":"2006","unstructured":"Orlikowsky T, Tr\u00fcg C, Neunhoeffer F, Deperschmidt M, Eichner M, Poets C. Lipopolysaccharide-binding protein in noninfected neonates and those with suspected early-onset bacterial infection. J Perinatol. 2006;26:115\u20139.","journal-title":"J Perinatol"},{"key":"2188_CR72","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(04)16206-5","volume":"363","author":"A Albillos","year":"2004","unstructured":"Albillos A, de-la-Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet. 2004;363:1608\u201310.","journal-title":"Lancet"},{"key":"2188_CR73","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2402637","volume":"249","author":"RR Schumann","year":"1990","unstructured":"Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, et al. Structure and function of lipopolysaccharide binding protein. Science. 1990;249:1429\u201331.","journal-title":"Science"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02188-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-02188-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02188-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T08:44:10Z","timestamp":1613378650000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-02188-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-02188-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"18 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For the subjects included in the explorative phase, the study protocol was approved by the local institutional review boards of CHU Hospital of Li\u00e8ge (Research Ethics Committee-human protocol #2005-020-Principal Investigator: Prof M. Malaise). For the subjects included in the validation phase, the study was approved by Ethics Committee of the Cliniques Universitaires Saint-Luc (Bruxelles; Study No. B403201317717).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}